General Practice · Yauco, PR
NPI
1871585265
Since 2005
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Hc 4 Box 11926
Yauco, PR, 00698
Phone (787) 403-7949
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.5M
1,569 prescriptions
Company payments, 2025
$373
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Saul Irizarry Vazquez prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 185 prescriptions and refills. In total Saul Irizarry Vazquez wrote 1,569 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 185 | 189 | 25 | $756K |
| Omega-3 Acid Ethyl Esters Generic | 168 | 203 | 33 | $12K |
| Dovato Dolutegravir Sodium/Lamivudine | 150 | 158 | 22 | $469K |
| Isentress Hd Raltegravir Potassium | 127 | 130 | 19 | $256K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 123 | 125 | 18 | $589K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 88 | 90 | 16 | $335K |
| Lansoprazole Generic | 83 | 107 | 15 | $1,600 |
| Pifeltro Doravirine | 65 | 65 | Under 11 | $114K |
| Prezcobix Darunavir/Cobicistat | 58 | 58 | Under 11 | $143K |
| Descovy Emtricitabine/Tenofov Alafenam | 58 | 62 | Under 11 | $136K |
| Rosuvastatin Calcium Generic | 54 | 66 | Under 11 | $428 |
| Juluca Dolutegravir/Rilpivirine | 53 | 53 | Under 11 | $188K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 52 | 52 | Under 11 | $206K |
| Tivicay Dolutegravir Sodium | 50 | 52 | Under 11 | $122K |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 23 | 31 | Under 11 | $3,227 |
Brand drugs: 1,053 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saul Irizarry Vazquez $373 ($373 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $312.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.